U.S. Pharmaceutical Sterility Testing Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Outsourcing, In-house), By Product, By Test (Sterility Testing, Bioburden Testing), By Sample (Pharmaceuticals, Medical Devices), By End-use, And Segment Forecasts

Table of Contents

Chapter 1. Research Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Market Definitions
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased Database
                       1.4.2. GVR’s Internal Database
                       1.4.3. Secondary Sources
                       1.4.4. Primary Research
                   1.5. Information Or Data Analysis
                       1.5.1. Data Analysis Models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Value chain based analysis (Model 2)
                       1.7.3. Multivariate Analysis (Model 3)
                   1.8. List Of Secondary Sources
                   1.9. List Of Abbreviations
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. U.S. Pharmaceutical Sterility Testing Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Supportive Government Investment in Healthcare Industry
                           3.2.1.2. Increasing R&D Activities
                           3.2.1.3. Increasing Number of Drug Launches
                           3.2.1.4. Increasing Focus on Quality and Sterility
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Compliance Issues While Outsourcing
                           3.2.2.2. Third Party Performance
                   3.3. Pricing Model Analysis
                   3.4. Technology Landscape
                   3.5. Market Analysis Tools
                       3.5.1. Porter’s Five Force Analysis
                       3.5.2. PESTEL by SWOT Analysis
                       3.5.3. COVID-19 Impact Analysis
Chapter 4. U.S. Pharmaceutical Sterility Testing Market: Type Estimates & Trend Analysis
                   4.1. U.S. Pharmaceutical Sterility Testing Market, By Type: Segment Dashboard
                   4.2. U.S. Pharmaceutical Sterility Testing Market, By Type: Movement Analysis
                   4.3. U.S. Pharmaceutical Sterility Testing Market Estimates & Forecasts, By Type, 2021-2033 (USD Million)
                   4.4. In-House
                       4.4.1. In-House Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   4.5. Outsourcing
                       4.5.1. Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Pharmaceutical Sterility Testing Market: Product Estimates & Trend Analysis
                   5.1. U.S. Pharmaceutical Sterility Testing Market, By Product: Segment Dashboard
                   5.2. U.S. Pharmaceutical Sterility Testing Market, By Product: Movement Analysis
                   5.3. U.S. Pharmaceutical Sterility Testing Market Estimates & Forecasts, By Product, 2021-2033 (USD Million)
                   5.4. Kits and Reagents
                       5.4.1. Kits and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   5.5. Instruments
                       5.5.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   5.6. Services
                       5.6.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Pharmaceutical Sterility Testing Market: Test Estimates & Trend Analysis
                   6.1. U.S. Pharmaceutical Sterility Testing Market, By Test: Segment Dashboard
                   6.2. U.S. Pharmaceutical Sterility Testing Market, By Test: Movement Analysis
                   6.3. U.S. Pharmaceutical Sterility Testing Market Estimates & Forecasts, By Test, 2021-2033 (USD Million)
                   6.4. Sterility Testing
                       6.4.1. Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.2. Membrane Filtration
                           6.4.2.1. Membrane Filtration Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.3. Direct Inoculation
                           6.4.3.1. Direct Inoculation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                       6.4.4. Product Flush
                           6.4.4.1. Product Flush Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.5. Bioburden Testing
                       6.5.1. Bioburden Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   6.6. Bacterial Endotoxin Testing
                       6.6.1. Bacterial Endotoxin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Pharmaceutical Sterility Testing Market: End-Use Estimates & Trend Analysis
                   7.1. U.S. Pharmaceutical Sterility Testing Market, By End-Use: Segment Dashboard
                   7.2. U.S. Pharmaceutical Sterility Testing Market, By End-Use: Movement Analysis
                   7.3. U.S. Pharmaceutical Sterility Testing Market Estimates & Forecasts, By End-Use, 2021-2033 (USD Million)
                   7.4. Compounding Pharmacies
                       7.4.1. Compounding Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.5. Medical Device Companies
                       7.5.1. Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.6. Pharmaceutical Companies
                       7.6.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   7.7. Others
                       7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. U.S. Pharmaceutical Sterility Testing Market: Sample Estimates & Trend Analysis
                   8.1. U.S. Pharmaceutical Sterility Testing Market, By Sample: Segment Dashboard
                   8.2. U.S. Pharmaceutical Sterility Testing Market, By Sample: Movement Analysis
                   8.3. U.S. Pharmaceutical Sterility Testing Market Estimates & Forecasts, By Sample, 2021-2033 (USD Million)
                   8.4. Pharmaceuticals
                       8.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.5. Medical Devices
                       8.5.1. Medical Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
                   8.6. Biopharmaceuticals
                       8.6.1. Biopharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                   9.1. Market Participant Categorization
                   9.2. Company Market Share/Assessment Analysis, 2024
                   9.3. Company Profiles
                       9.3.1. Pacific Biolabs
                           9.3.1.1. Company overview
                           9.3.1.2. Financial performance
                           9.3.1.3. Service benchmarking
                           9.3.1.4. Strategic initiatives
                       9.3.2. Steris Plc
                           9.3.2.1. Company overview
                           9.3.2.2. Financial performance
                           9.3.2.3. Service benchmarking
                           9.3.2.4. Strategic initiatives
                       9.3.3. Boston Analytical
                           9.3.3.1. Company overview
                           9.3.3.2. Financial performance
                           9.3.3.3. Service benchmarking
                           9.3.3.4. Strategic initiatives
                       9.3.4. Nelson Laboratories, LLC (Sotera Health)
                           9.3.4.1. Company overview
                           9.3.4.2. Financial performance
                           9.3.4.3. Service benchmarking
                           9.3.4.4. Strategic initiatives
                       9.3.5. Sartorius AG
                           9.3.5.1. Company overview
                           9.3.5.2. Financial performance
                           9.3.5.3. Service benchmarking
                           9.3.5.4. Strategic initiatives
                       9.3.6. SOLVIAS AG
                           9.3.6.1. Company overview
                           9.3.6.2. Financial performance
                           9.3.6.3. Service benchmarking
                           9.3.6.4. Strategic initiatives
                       9.3.7. SGS SA
                           9.3.7.1. Company overview
                           9.3.7.2. Financial performance
                           9.3.7.3. Service benchmarking
                           9.3.7.4. Strategic initiatives
                       9.3.8. Labcorp
                           9.3.8.1. Company overview
                           9.3.8.2. Financial performance
                           9.3.8.3. Service benchmarking
                           9.3.8.4. Strategic initiatives
                       9.3.9. Pace Analytical
                           9.3.9.1. Company overview
                           9.3.9.2. Financial performance
                           9.3.9.3. Service benchmarking
                           9.3.9.4. Strategic initiatives
                       9.3.10. Charles River Laboratories
                           9.3.10.1. Company overview
                           9.3.10.2. Financial performance
                           9.3.10.3. Service benchmarking
                           9.3.10.4. Strategic initiatives
                       9.3.11. Thermo Fisher Scientific, Inc.
                           9.3.11.1. Company overview
                           9.3.11.2. Financial performance
                           9.3.11.3. Service benchmarking
                           9.3.11.4. Strategic initiatives
                       9.3.12. Rapid Micro Biosystems
                           9.3.12.1. Company overview
                           9.3.12.2. Financial performance
                           9.3.12.3. Service benchmarking
                           9.3.12.4. Strategic initiatives
                       9.3.13. Almac Group
                           9.3.13.1. Company overview
                           9.3.13.2. Financial performance
                           9.3.13.3. Service benchmarking
                           9.3.13.4. Strategic initiatives
Chapter 10  Key Recommendations

List of Tables

Table 1. List of Tables
Table 2. List of Secondary Sources
Table 3. List of Abbreviations
Table 4. U.S. Pharmaceutical Sterility Testing Market Estimates and Forecasts, by Type, 2021 - 2033 (USD Million)
Table 5. U.S. Pharmaceutical Sterility Testing Market Estimates and Forecasts, by Product, 2021 - 2033 (USD Million)
Table 6. U.S. Pharmaceutical Sterility Testing Market Estimates and Forecasts, by Test, 2021 - 2033 (USD Million)
Table 7. U.S. Pharmaceutical Sterility Testing Market Estimates and Forecasts, by Sterility Testing, 2021 - 2033 (USD Million)
Table 8. U.S. Pharmaceutical Sterility Testing Market Estimates and Forecasts, by End-Use, 2021 - 2033 (USD Million)
Table 9. U.S. Pharmaceutical Sterility Testing Market Estimates and Forecasts, by Sample, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Value-chain-based sizing & forecasting
Fig. 8 QFD model sizing & forecasting
Fig. 9 Bottom-up approach
Fig. 10 Market snapshot
Fig. 11 Segment snapshot 1
Fig. 12 Segment snapshot 2
Fig. 13 Competitive landscape snapshot
Fig. 14 Parent market outlook, 2024 (USD Billion)
Fig. 15 Ancillary market outlook, 2024 (USD Billion)
Fig. 16 U.S. Pharmaceutical Sterility Testing Market Dynamics
Fig. 17 Porter’s five forces analysis
Fig. 18 PESTEL analysis
Fig. 19 U.S. Pharmaceutical Sterility Testing Market: Type outlook and key takeaways
Fig. 20 U.S. Pharmaceutical Sterility Testing Market: Type movement analysis
Fig. 21 In-House Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 22 Outsourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 23 U.S. Pharmaceutical Sterility Testing Market: Product outlook and key takeaways
Fig. 24 U.S. Pharmaceutical Sterility Testing Market: Product movement analysis
Fig. 25 Kits and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 26 Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 27 Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 28 U.S. Pharmaceutical Sterility Testing Market: Test outlook and key takeaways
Fig. 29 U.S. Pharmaceutical Sterility Testing Market: Test movement analysis
Fig. 30 Sterility Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 31 Membrane Filtration Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 32 Direct Inoculation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 33 Product Flush Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 34 Bioburden Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 35 Bacterial Endotoxin Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 36 U.S. Pharmaceutical Sterility Testing Market: End-Use outlook and key takeaways
Fig. 37 U.S. Pharmaceutical Sterility Testing Market: End-Use movement analysis
Fig. 38 Compounding Pharmacies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 39 Medical Device Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 40 Pharmaceutical Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 41 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 42 U.S. Pharmaceutical Sterility Testing Market: Sample outlook and key takeaways
Fig. 43 U.S. Pharmaceutical Sterility Testing Market: Sample movement analysis
Fig. 44 Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 45 Medical Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 46 Biopharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Key company categorization
Fig. 48 Service heat map analysis
Fig. 49 Strategic framework